New York, NY, United States of America

Andrew Pincetic

This inventor holds 8 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: The Rockefeller University, Sloan-Kettering Institute for Cancer Research. Active years: 2016-2025.

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Andrew Pincetic: Innovator in Anti-Inflammatory Research

Introduction

Andrew Pincetic is a notable inventor based in New York, NY (US). He has made significant contributions to the field of anti-inflammatory research, holding a total of 8 patents. His work focuses on developing innovative solutions for treating inflammatory disorders.

Latest Patents

Among his latest patents, Andrew has developed anti-inflammatory polypeptides. This invention concerns anti-inflammatory agents, compositions, and methods for treating inflammatory disorders. His research aims to provide effective treatments for various inflammatory conditions.

Career Highlights

Andrew has worked at prestigious institutions, including The Rockefeller University and the Sloan Kettering Institute for Cancer Research. His experience in these renowned organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Andrew has collaborated with esteemed colleagues, including Jeffrey V. Ravetch and Ping Wang. These partnerships have further enriched his research and innovation in the field of anti-inflammatory agents.

Conclusion

Andrew Pincetic is a dedicated inventor whose work in anti-inflammatory research has the potential to impact many lives. His contributions to the field are noteworthy, and his ongoing research continues to pave the way for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…